Polymorphisms of endothelial nitric oxide synthase and hypoxia-inducible factor 1 alpha genes play a role in susceptibility to coronary artery disease
Open Access
- 21 September 2018
- journal article
- research article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 5 (9), 2688-2696
- https://doi.org/10.15419/bmrat.v5i9.480
Abstract
Objective: Genetics is a known factor in the susceptibility to cardiovascular disease. In this study, polymorphisms of endothelial nitric oxide synthase (eNOS) (T876C and G894T) and hypoxiainducible factor 1 (HIF1) (rs10873142 and rs41508050) in coronary artery disease were compared with healthy subjects, and the relationship between these mutations and risk of coronary artery disease (CAD) was assessed. Methods: Blood samples were collected from 138 patients with obstructive CAD and 115 healthy subjects. Polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP), Griess test, and enzyme-linked immunosorbent assay (ELISA) were used to measure serum nitric oxide (NO) and paraoxonase antioxidant. Independent t-test was used to examine the relationship between variables. Results: There was no significant difference between genotype frequency in healthy subjects and patients for eNOS and HIF1 alpha polymorphisms. There was no significant difference between these polymorphisms and age, sex, hypertension and lipidemia. Furthermore, the difference in mean serum levels of NO in different genotypes of the G894T gene was not significant between the patient and control groups. However, the difference in mean serum NO levels in different genotypes of the T786C gene was significant between the patient and control groups such that minimum and maximum serum NO levels were observed in individuals bearing TT and TC genotypes, respectively. The difference in mean serum NO levels was higher in patients than in controls, and was statistically significant. Conclusions: The results suggest that the T876C polymorphism could be associated with low serum NO level and implicated as a risk factor for developing CAD. Furthermore, our findings indicate that genetics may not be involved in susceptibility to CAD; however, further comprehensive studies are required.Keywords
This publication has 16 references indexed in Scilit:
- Genetics of Coronary Artery Disease and Myocardial Infarction - 2013Current Cardiology Reports, 2013
- Study on the role of environmental parameters and HIF-1A gene polymorphism in coronary collateral formation among patients with ischemic heart diseaseClinical Biochemistry, 2011
- The A1298C Mutation in Methylenetetrahydrofolate Reductase Gene and Its Association With Idiopathic Venous Thrombosis in an Iranian PopulationLaboratory Medicine, 2011
- Genetic Polymorphisms of Hypoxia-Inducible Factor-1 Alpha and Cardiovascular Disease in Hemodialysis PatientsNephron Clinical Practice, 2009
- Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart diseaseLipids in Health and Disease, 2008
- The Molecular Analysis of β-Thalassemia Mutations in Lorestan Province, IranHemoglobin, 2007
- Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphismsNitric Oxide, 2005
- The role of heme oxygenase-1 promoter polymorphisms in human diseaseFree Radical Biology & Medicine, 2004
- Identification of Hypoxia-response Element in the Human Endothelial Nitric-oxide Synthase Gene PromoterOnline Journal of Public Health Informatics, 2003
- A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and NitriteNitric Oxide, 2001